Multiple-strain malaria infection and its impacts on \textit{Plasmodium falciparum} resistance to antimalarial therapy: a mathematical modelling perspective (Q2003714)
From MaRDI portal
| This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Multiple-strain malaria infection and its impacts on \textit{Plasmodium falciparum} resistance to antimalarial therapy: a mathematical modelling perspective |
scientific article; zbMATH DE number 7077780
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Multiple-strain malaria infection and its impacts on \textit{Plasmodium falciparum} resistance to antimalarial therapy: a mathematical modelling perspective |
scientific article; zbMATH DE number 7077780 |
Statements
Multiple-strain malaria infection and its impacts on \textit{Plasmodium falciparum} resistance to antimalarial therapy: a mathematical modelling perspective (English)
0 references
9 July 2019
0 references
Summary: The emergence of parasite resistance to antimalarial drugs has contributed significantly to global human mortality and morbidity due to malaria infection. The impacts of multiple-strain malarial parasite infection have further generated a lot of scientific interest. In this paper, we demonstrate, using the epidemiological model, the effects of parasite resistance and competition between the strains on the dynamics and control of \textit{Plasmodium falciparum} malaria. The analysed model has a trivial equilibrium point which is locally asymptotically stable when the parasite's effective reproduction number is less than unity. Using contour plots, we observed that the efficacy of antimalarial drugs used, the rate of development of resistance, and the rate of infection by merozoites are the most important parameters in the multiple-strain \textit{P. falciparum} infection and control model. Although the drug-resistant strain is shown to be less fit, the presence of both strains in the human host has a huge impact on the cost and success of antimalarial treatment. To reduce the emergence of resistant strains, it is vital that only effective antimalarial drugs are administered to patients in hospitals, especially in malaria-endemic regions. Our results emphasize the call for regular and strict surveillance on the use and distribution of antimalarial drugs in health facilities in malaria-endemic countries.
0 references
multiple-strain malaria infection
0 references
\textit{Plasmodium falciparum} resistance
0 references
antimalarial therapy
0 references
0 references
0 references